Skip to content

DOKTER EVA DE MEYER: what changed

BE 0828.082.961NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€55,212
2024 · €51,860+€3,352
Equity
€219,159
2024 · €196,773+€22,386
Cash
€10,252
2024 · €11,515-€1,263
Balance sheet total
€236,993
2024 · €219,755+€17,239

Largest movements

2024 to 2025
Assets
  • Current investments +€31,456

    up €31,456 (+20.5%), from €153,575 to €185,031

  • Deferred charges and accrued income -€9,598

    down €9,598 (-24.1%), from €39,807 to €30,208

Equity and liabilities
  • Reserves +€22,386

    up €22,386 (+12.7%), from €176,773 to €199,159

    of which Distributable reserves: +€22,386

  • Other debts -€7,215

    down €7,215 (-44.3%), from €16,297 to €9,082

  • Tax, wage and social debts +€2,909

    up €2,909 (+69.1%), from €4,208 to €7,118

Income statement
  • Gross operating margin +€3,176

    up €3,176 (+4.6%), from €69,172 to €72,347

  • Financial income +€3,094

    up €3,094 (+69.0%), from €4,484 to €7,578

  • Financial charges +€2,703

    up €2,703, from -€121 to €2,582

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €51,860
Gross operating margin +€3,176
Other operating charges +€165
Financial income +€3,094
Financial charges -€2,703
Taxes -€379
Result 2025 €55,212
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€63,019
Investment -€31,456
Financing -€32,826
Cash 2024 €11,515
Net result for the year +€55,212
Depreciation +€1,575
Receivables within one year +€1,780
Deferred charges and accrued income +€9,598
Trade debts -€181
Tax, wage and social debts +€2,909
Other debts -€7,215
Accrued charges and deferred income -€661
Current investments -€31,456
Contributions, distributions and other -€32,826
Cash 2025 €10,252
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €219,755 €236,993 +€17,239 +7.8%
Fixed assets 21/28 €2,908 €1,332 -€1,575 -54.2%
Tangible fixed assets 22/27 €2,908 €1,332 -€1,575 -54.2%
Plant, machinery and equipment 23 €666 €259 -€406 -61.0%
Furniture and vehicles 24 €2,242 €1,073 -€1,169 -52.1%
Current assets 29/58 €216,847 €235,661 +€18,814 +8.7%
Amounts receivable after more than one year 29 €10,000 €10,000 = 0.0%
Other amounts receivable 291 €10,000 €10,000 = 0.0%
Amounts receivable within one year 40/41 €1,950 €170 -€1,780 -91.3%
Trade receivables 40 - €170 +€170
Other amounts receivable 41 €1,950 - -€1,950
Current investments 50/53 €153,575 €185,031 +€31,456 +20.5%
Cash at bank and in hand 54/58 €11,515 €10,252 -€1,263 -11.0%
Deferred charges and accrued income 490/1 €39,807 €30,208 -€9,598 -24.1%
Total equity and liabilities 10/49 €219,755 €236,993 +€17,239 +7.8%
Equity 10/15 €196,773 €219,159 +€22,386 +11.4%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €176,773 €199,159 +€22,386 +12.7%
Tax-exempt reserves 132 €187 €187 = 0.0%
Distributable reserves 133 €176,586 €198,972 +€22,386 +12.7%
Amounts payable 17/49 €22,982 €17,834 -€5,148 -22.4%
Amounts payable within one year 42/48 €22,320 €17,834 -€4,486 -20.1%
Trade debts 44 €1,815 €1,634 -€181 -9.9%
Suppliers 440/4 €1,815 €1,634 -€181 -9.9%
Taxes, remuneration and social security 45 €4,208 €7,118 +€2,909 +69.1%
Taxes 450/3 €4,208 €7,118 +€2,909 +69.1%
Other amounts payable 47/48 €16,297 €9,082 -€7,215 -44.3%
Accrued charges and deferred income 492/3 €661 - -€661
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,575 €1,575 = 0.0%
Other operating charges 640/8 €795 €630 -€165 -20.8%
Gross operating margin 9900 €69,172 €72,347 +€3,176 +4.6%
Operating profit (loss) 9901 €66,801 €70,142 +€3,341 +5.0%
Financial income 75/76B €4,484 €7,578 +€3,094 +69.0%
Recurring financial income 75 €4,484 €7,578 +€3,094 +69.0%
Financial charges 65/66B -€121 €2,582 +€2,703
Recurring financial charges 65 -€121 €2,582 +€2,703
Profit (loss) for the period before taxes 9903 €71,407 €75,138 +€3,731 +5.2%
Income taxes 67/77 €19,546 €19,926 +€379 +1.9%
Profit (loss) for the period 9904 €51,860 €55,212 +€3,352 +6.5%
Profit (loss) for the period to be appropriated 9905 €51,860 €55,212 +€3,352 +6.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€272,312 to €337,405

Midpoint €299,434 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €219,159
Capitalised earnings €325,464 to €455,650
Indication €272,312 to €337,405

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€219,159
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€219,159

Capitalised earnings

net result for the year (9904)
2025
€55,212
2024
€51,860
2023
€29,623
2022
€23,125
2021
€11,950
Average result
€45,565
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€325,464 / €379,708 / €455,650

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.